NEW YORK (GenomeWeb) – Personalized medicine firm Perthera said today that it has completed an $8.7 million Series A funding round.

The round was led by Pilot Growth Equity, a technology growth equity firm with offices in San Francisco, New York, and Washington, DC, which was the sole institutional investor.

Launched in 2013 by George Mason University researcher Emanuel Petricoin and venture capitalist Dendy Young, McLean, Virginia-based Perthera provides molecular profiling of cancer patients to help physicians guide their treatments.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.